The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial

BACKGROUND: Clomiphene citrate (CC) is first line treatment in women with World Health Organization (WHO) type II anovulation and polycystic ovary syndrome (PCOS). Whereas 60% to 85% of these women will ovulate on CC, only about one half will have conceived after six cycles. If women do not conceive...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahuis, Marleen J, Weiss, Nienke S, van der Veen, Fulco, Mol, Ben Willem J, Hompes, Peter G, Oosterhuis, Jur, Lambalk, Nils B, Smeenk, Jesper MJ, Koks, Carolien AM, van Golde, Ron JT, Laven, Joop SE, Cohlen, Ben J, Fleischer, Kathrin, Goverde, Angelique J, Gerards, Marie H, Klijn, Nicole F, Nekrui, Lizka CM, van Rooij, Ilse AJ, Hoozemans, Diederik A, van Wely, Madelon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828011/
https://www.ncbi.nlm.nih.gov/pubmed/24160333
http://dx.doi.org/10.1186/1472-6874-13-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828011/
https://www.ncbi.nlm.nih.gov/pubmed/24160333
http://dx.doi.org/10.1186/1472-6874-13-42

Ejemplares similares